Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03529799 · ClinicalTrials.gov registry record · NA

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

A NA study, sponsored by University of Miami.

Terminated
Registry status
NA
Development phase
40
Enrollment target

NCT03529799: Clinical Trial NA study, sponsored by University of Miami.

NCT03529799 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03529799, a NA study, was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study aims to determine the validity and safety of disparity driven vergence using a portable goggle system (I-PAS) using a pseudorandom ternary sequence of frequencies for testing.

Primary Outcome

Pseudorandom Ternary Sequence of Frequency (reported in Hertz) will be measured via mergence testing using the IPAS goggles.

Interventions

  • DEVICE I-PAS Goggles

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-04-20
Est. Completion 2019-09-25
Phase NA
University of Miami

721 total trials

Why NCT03529799 stopped before completion

NCT03529799 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which I-PAS Goggles is the first listed.

NCT03529799 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03529799 about?

NCT03529799 is a clinical study titled "Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)". This study aims to determine the validity and safety of disparity driven vergence using a portable goggle system (I-PAS) using a pseudorandom ternary sequence of frequencies for testing.

What is the current status of trial NCT03529799?

This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2018-04-20. Estimated completion is 2019-09-25.

What interventions are being tested in trial NCT03529799?

The interventions under investigation include: I-PAS Goggles (DEVICE).

Who is sponsoring clinical trial NCT03529799?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03529799's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03529799, the US trial registry maintained by the National Library of Medicine. NCT03529799 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.